Patient Characteristics and Costs Associated With COVID-19-Related Medical Care Among Medicare Fee-for-Service Beneficiaries.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 1 6 2021
medline: 1 9 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

New cases of COVID-19 continue to occur daily in the United States, and the need for medical treatments continues to grow. Knowledge of the direct medical costs of COVID-19 treatments is limited. To examine the characteristics of older adults with COVID-19 and their costs for COVID-19-related medical care. Retrospective observational study. Medical claims for Medicare fee-for-service (FFS) beneficiaries. Medicare FFS beneficiaries aged 65 years or older who had a COVID-19-related medical encounter during April through December 2020. Patient characteristics and direct medical costs of COVID-19-related hospitalizations and outpatient visits. Among 28.1 million Medicare FFS beneficiaries, 1 181 127 (4.2%) sought COVID-19-related medical care. Among these patients, 23.0% had an inpatient stay and 4.2% died during hospitalization. The majority of the patients were female (57.0%), non-Hispanic White (79.6%), and residents of an urban county (77.2%). Medicare FFS costs for COVID-19-related medical care were $6.3 billion; 92.6% of costs were for hospitalizations. The mean hospitalization cost was $21 752, and the mean length of stay was 9.2 days; hospitalization cost and length of stay were higher if the patient needed a ventilator ($49 441 and 17.1 days) or died ($32 015 and 11.3 days). The mean cost per outpatient visit was $164. Patients aged 75 years or older were more likely to be hospitalized, but their hospitalizations were associated with lower costs than for younger patients. Male sex and non-White race/ethnicity were associated with higher probability of being hospitalized and higher medical costs. Results are based on Medicare FFS patients. The COVID-19 pandemic has resulted in substantial disease and economic burden among older Americans, particularly those of non-White race/ethnicity. None.

Sections du résumé

BACKGROUND
New cases of COVID-19 continue to occur daily in the United States, and the need for medical treatments continues to grow. Knowledge of the direct medical costs of COVID-19 treatments is limited.
OBJECTIVE
To examine the characteristics of older adults with COVID-19 and their costs for COVID-19-related medical care.
DESIGN
Retrospective observational study.
SETTING
Medical claims for Medicare fee-for-service (FFS) beneficiaries.
PATIENTS
Medicare FFS beneficiaries aged 65 years or older who had a COVID-19-related medical encounter during April through December 2020.
MEASUREMENTS
Patient characteristics and direct medical costs of COVID-19-related hospitalizations and outpatient visits.
RESULTS
Among 28.1 million Medicare FFS beneficiaries, 1 181 127 (4.2%) sought COVID-19-related medical care. Among these patients, 23.0% had an inpatient stay and 4.2% died during hospitalization. The majority of the patients were female (57.0%), non-Hispanic White (79.6%), and residents of an urban county (77.2%). Medicare FFS costs for COVID-19-related medical care were $6.3 billion; 92.6% of costs were for hospitalizations. The mean hospitalization cost was $21 752, and the mean length of stay was 9.2 days; hospitalization cost and length of stay were higher if the patient needed a ventilator ($49 441 and 17.1 days) or died ($32 015 and 11.3 days). The mean cost per outpatient visit was $164. Patients aged 75 years or older were more likely to be hospitalized, but their hospitalizations were associated with lower costs than for younger patients. Male sex and non-White race/ethnicity were associated with higher probability of being hospitalized and higher medical costs.
LIMITATION
Results are based on Medicare FFS patients.
CONCLUSION
The COVID-19 pandemic has resulted in substantial disease and economic burden among older Americans, particularly those of non-White race/ethnicity.
PRIMARY FUNDING SOURCE
None.

Identifiants

pubmed: 34058109
doi: 10.7326/M21-1102
pmc: PMC8252832
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1101-1109

Commentaires et corrections

Type : CommentIn

Auteurs

Yuping Tsai (Y)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (Y.T., T.M.V., F.Z.).

Tara M Vogt (TM)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (Y.T., T.M.V., F.Z.).

Fangjun Zhou (F)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (Y.T., T.M.V., F.Z.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH